Johnson & Johnson Innovation Medicine has submitted a request to the FDA to approve Tremfya as a treatment for ulcerative ...

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited ...

Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.

TV personality Dr Oz has been nominated by President-elect Donald Trump to lead the Centers for Medicare and Medicaid ...

The companies have teamed up to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell ...

RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down ...

Technology has changed the clinical trial landscape forever, with application programming interfaces (APIs) growing in ...

The UK’s NICE has rejected a deal for the reimbursement of Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu for ...